Roche Holding AG
SIX:ROG
Roche Holding AG
SIX:ROG
Price:
222.6 CHF
0.72%
Updated:
Apr 29, 2024
Roche Holding AG
Income from Continuing Operations
|
Roche Holding AG
Income from Continuing Operations Peer Comparison
Comparables:
NOVN
NLSP
S
SDZ
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Income from Continuing Operations
CHf12.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
Novartis AG
SIX:NOVN
|
Income from Continuing Operations
$8.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Income from Continuing Operations
-$16.5m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Income from Continuing Operations
$850m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Income from Continuing Operations?
Income from Continuing Operations
12.4B
CHF
12.4B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Income from Continuing Operations amounts to 12.4B CHF.
What is Roche Holding AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
1%
1%
Over the last year, the Income from Continuing Operations growth was -9%. The average annual Income from Continuing Operations growth rates for Roche Holding AG have been -6% over the past three years , 3% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
